Since 1996, The LAM Foundation has been funding significant research that has led to tremendous progress in the treatment options and a possible cure for lymphangioleiomyomatosis. Today, The LAM Foundation is the largest funder of LAM research, outside of the National Institutes of Health. 

The LAM Foundation-funded research has led to many major discoveries, including: 
- Evidence that LAM is genetic 
- Identification of a LAM gene 
- Molecular explanation for abnormal smooth muscle cell growth in LAM, which has led to new therapies for LAM 
- FDA approved treatment for LAM 

The LAM Foundation offers the following research awards and grants: 

• Pilot and Feasibility Grant
• Career Development Research Grant
• Established Investigator Research Grant
• Out of Cycle Grant Opportunities

Deadline: June 15 (REQUIRED letter of intent)